CMV pneumonia following Temozolomide in Primary CNS Lymphoma.
Temozolomide (TMZ) is a second-generation alkylating agent introduced to therapy of primary brain tumors. Using TMZ there is an increased risk of infection. Literature reported several cases of PJ pneumonia but only 6 cases of CMV disease. This case presented the 1st patient with persistent CMV rea...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1891 |